FDA Approved: EVOXAC — Supplemental Application (Cosette Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Evoxac (cevimeline hydrochloride) from Cosette Pharmaceuticals, updating its labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome

Drugs mentioned

• EVOXAC (cevimeline hydrochloride)

Snippet

SUPPL AP for EVOXAC (CEVIMELINE HYDROCHLORIDE)